Custom Biomarkers

AltheaDx has identified multiple gene expression markers that show a differential response between patients with a poor prognosis and those with a good prognosis... more

Patient response to drugs targeting the Epidermal Growth Factor Receptor (EGFR) is dependent on mutations in the EGFR itself as well as its downstream signaling proteins... more

Platinum drug-resistant patients have a genetically advanced form of cancer and are unlikely to benefit from cytotoxic therapy... more